Ion Mobility Mass Spectrometry of Glyco-and Phospho-Peptides

Significance of the Topic

Ion mobility mass spectrometry (IM-MS) adds an orthogonal separation dimension to liquid chromatography–tandem mass spectrometry (LC-MS/MS), enabling detailed analysis of complex post-translational modifications such as glycosylation and phosphorylation. By exploiting differences in gas-phase mobility, researchers can distinguish structural and positional isomers that often co-elute chromatographically, improving sensitivity, specificity and quantitative accuracy in proteomics workflows.

Study Objectives and Overview

This study evaluates the performance of trapped ion mobility spectrometry coupled to time-of-flight (TIMS-TOF) analysis on two challenging sample types: lectin-enriched human plasma glycopeptides and TiO2-enriched HeLa phosphopeptides. Comparative experiments on a Bruker timsTOF Pro and a Thermo Q-Exactive HF-X Orbitrap assess instrument sensitivity, depth of coverage and the ability to resolve isomeric species by retention time and ion mobility.

Methodology and Instrumentation

Samples were prepared by reduction, alkylation, trypsin digestion and specific enrichment for glyco- or phosphopeptides. LC-MS/MS acquisitions employed 90- to 130-minute reverse-phase gradients. Data-dependent fragmentation with collision energies optimized for glycopeptides (31–51 eV vs. 32–64 eV) was performed on the timsTOF Pro using the PASEF acquisition strategy. Parallel analyses on the Q-Exactive HF-X utilized standard high-resolution Orbitrap MS/MS. Data were searched with ByonicTM against human protein databases and focused glycan and phosphorylation modifications.

Main Results and Discussion

• timsTOF Pro produced 439,000 MS2 spectra, identifying over 5,200 proteins, 92,900 PSMs and 32,957 unique peptides at 1% FDR, outperforming the Orbitrap which yielded 4,119 proteins, 37,307 PSMs and 21,978 unique peptides.
• Collision energy optimization improved glycopeptide identifications by up to 50%, with higher energies (32–64 eV) delivering deeper coverage.
• Ion mobility successfully separated several glycopeptide isomers based on glycan composition and linkage, revealing distinct mobility distributions for sialylated variants.
• Phosphopeptide positional isomers exhibited limited mobility separation but benefited from the additional dimension to resolve co-eluting species when retention time differences were insufficient.

Benefits and Practical Applications

Integrating IM-MS into glyco- and phosphoproteomics workflows enhances depth and confidence in PTM site localization, supports discrimination of isomeric forms and boosts throughput through the PASEF acquisition mode. These capabilities are valuable for biomarker discovery, quality control in biopharmaceutical glycoprotein analysis and detailed mapping of signaling networks.

Future Trends and Opportunities

Advances in ion mobility resolution and multi-dimensional data analysis will further refine structural characterization of complex glycans and phosphopeptide isomers. Machine learning-driven peak annotation and integration of ion mobility CCS libraries promise automated identification of subtle isomeric differences. Expanding mobility-based quantitation methods may yield more robust workflows for clinical proteomics and biologics characterization.

Conclusion

This work demonstrates that TIMS-TOF PASEF substantially improves proteome coverage and adds an effective dimension for isomer separation in glyco- and phosphopeptide analysis. While mobility separation of positional phospho-isomers remains challenging, the combined retention time and ion mobility approach enhances the overall analytical performance.

Reference

• Zhu, J. et al. Glycopeptide separation by ion mobility. Journal of the American Society for Mass Spectrometry, PMID 25840811.
• HUPO Human Glycoproteomics Initiative (HGI) study on glycan databases and search strategies.